Eikon Therapeutics, Inc. Common Stock (EIKN)

Price$11.55

Favorite Metrics

Price vs S&P 500 (4W)-8.82%

Market Capitalization$644.25M

All Metrics

Price vs S&P 500 (YTD)-25.47%

10-Day Avg Trading Volume0.36M

EPS (Annual)$-6.01

ROI (Annual)-114.80%

Cash / Share (Quarterly)$6.22

ROA (Last FY)-54.52%

Cash Flow / Share (Annual)$-4.36

P/B Ratio2.28x

Net Income / Employee (Annual)$-1

EPS Incl Extra (Annual)$-6.01

Current Ratio (Annual)6.34x

Quick Ratio (Quarterly)6.12x

3-Month Avg Trading Volume0.49M

52-Week High$17.40

EPS Excl Extra (Annual)$-6.01

Quick Ratio (Annual)6.12x

Total Debt / Equity (Annual)0.00x

Current Ratio (Quarterly)6.34x

Revenue / Employee (Annual)$0

Cash / Share (Annual)$6.22

ROE (Last FY)-114.80%

EPS Basic Excl Extra (Annual)$-6.01

Total Debt / Equity (Quarterly)0.00x

Revenue / Share (Annual)$0.00

Year-to-Date Return-20.67%

5-Day Price Return20.57%

EPS Normalized (Annual)$-6.01

Month-to-Date Return12.48%

EBITD / Share (Annual)$-5.93

Beta2.77x

52-Week Low$8.58

Analyst Recommendations

Apr 2026

3.92

About

Eikon Therapeutics is a late-stage clinical biopharmaceutical company developing novel medicines to address serious unmet medical needs using its proprietary drug discovery platform. The company is advancing five product candidates (EIK1001, EIK1003, EIK1004, EIK1005, and EIK1006) through clinical development.